This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2006.
Company Filing History:
Years Active: 2006
Title: Weijang Zhang: Innovator in Erythromycin Derivatives
Introduction
Weijang Zhang is a notable inventor based in Grayslake, IL (US). He has made significant contributions to the field of chemistry, particularly in the synthesis of erythromycin derivatives. His innovative approach has led to advancements in arylation techniques, which are crucial for pharmaceutical development.
Latest Patents
Weijang Zhang holds a patent for an "Arylation method for the functionalization of O-allyl erythromycin derivatives." This patent describes an efficient arylation technique that utilizes a modified Heck reaction. This method employs less than six mole percent of palladium catalyst and eliminates the need for phosphine. The modified Heck reaction allows for the synthesis of an O-alkenylaryl macrolide in a significantly shorter reaction time compared to conventional methods. This innovation can be applied in various methods for preparing O-alkenylaryl erythromycin derivatives.
Career Highlights
Weijang Zhang is associated with Abbott Laboratories Corporation, where he continues to contribute to research and development in the pharmaceutical industry. His work focuses on improving synthesis methods that can enhance the efficacy and efficiency of drug development.
Collaborations
He has collaborated with notable colleagues, including Bikshandarkoil A Narayanan and Matthew John Peterson. These collaborations have further enriched his research and contributed to the advancement of their shared goals in the field of chemistry.
Conclusion
Weijang Zhang's innovative contributions to the synthesis of erythromycin derivatives highlight his role as a significant inventor in the pharmaceutical industry. His patented methods are paving the way for more efficient drug development processes.